Ideas to action: independent research for global prosperity
Research
Innovative, independent, peer-reviewed. Explore the latest economic research and policy proposals from CGD’s global development experts.
POLICY PAPERS
April 15, 2024
WORKING PAPERS
April 15, 2024
CGD NOTES
April 11, 2024
WORKING PAPERS
April 11, 2024
All Research
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Research
BRIEFS
April 07, 2021
In this policy brief, we summarize the findings of a CGD working paper, The Gendered Dimensions of Social Protection in the COVID-19 Context. We explore the role of social protection, with an emphasis on social assistance policies and programs, in addressing increasing poverty, food insecurity, unpa...
CGD NOTES
March 26, 2021
Safe and efficacious vaccines are our best tools for defeating COVID-19, and an unprecedented research and development effort has led to 12 vaccines being approved for full, emergency, or limited use, globally. But to vaccinate the global population as quickly as possible requires additional product...
CGD NOTES
March 18, 2021
Even before the COVID-19 pandemic, fragile states around the world struggled to manage complex and interacting risks. Facing macroeconomic stressors on top of a fragile peace, many countries found themselves balancing precariously between tipping points, knowing that interventions that might ease ec...
BRIEFS
December 22, 2020
Always considering gender is smart foreign policy. Globally, gender plays a significant role in determining the barriers people face and the opportunities they have available to them—including their access to economic opportunities and leadership positions, or protection from violence or climate cha...
POLICY PAPERS
December 21, 2020
We develop screens and principles designed to maximise the impact of aid, especially in richer recipients. All else equal, a dollar spent in the poorest countries will have a larger impact on well-being than a dollar spent in richer countries, so ODA should be concentrated in those countries.
WORKING PAPERS
December 14, 2020
Between 2011 and 2016, the Affordable Medicines Facility-Malaria (AMFm) subsidy program substantially increased access to WHO prequalified artemisinin combination therapies (ACTs) through Africa’s private sector pharmacies and drug-sellers. While the program was rigorously and extensively evaluated,...